![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Sanborn Rachel E Sandler Alan B
Publisher: Informa Healthcare
ISSN: 1474-0338
Source: Expert Opinion on Drug Safety, Vol.5, Iss.2, 2006-03, pp. : 289-301
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Efficacy and Safety of Bevacizumab in Glioblastomas
Current Medicinal Chemistry, Vol. 19, Iss. 7, 2012-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bevacizumab: Haemoptysis: case report
Reactions Weekly, Vol. 1, Iss. 1163, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bevacizumab: Hypotension: case report
Reactions Weekly, Vol. 1, Iss. 1187, 2008-01 ,pp. :